Turn on more accessible mode

Turn off more accessible mode

Skip Ribbon Commands

Skip to main content

Print Page

Cancer Resource Center

Help (new window)

Upcoming Events

View Our Calendar

See all classes, support groups, and other events >>

Ask a Health Educator for help!

Call us toll free at:
1-866-206-9959

Email us at: cancerinfo@mainehealth.org

Look up a Cancer by Disease

A B C D E F G H I J K L M N O P Q R S T U V W X Y ZLook up Body Part

Clinical Trials in Maine

Chemotherapy and Radiation in Treating Patients With Stage 3 Non-Small Cell Lung Cancer A Study for Patients With Small-Cell Lung Cancer Study of Patients With Advanced Non-Small Cell Lung Cancer Study for Patients With Recurrent or Metastatic Squamous Cell Head and Neck Cancer A Study in Second Line Metastatic Colorectal Cancer A Study of Ramucirumab in Patients With Gastric, Esophageal and Gastroesophageal Cancer Early Stage Breast Cancer Nonsquamous Non-Small Cell Lung Cancer ALK Positive Non Squamous Cancer Of The Lung Metastatic or Locally Recurrent Breast Cancer Non-Hodgkin's Lymphoma (NHL) or Mantle Cell Lymphoma (MCL)Advanced Indolent Non-Hodgkin's Lymphoma (NHL) or Mantle Cell Lymphoma (MCL)Metastatic Adenocarcinoma of the Pancreas Prostate Cancer Advanced Prostate Cancer Symptomatic Chronic Lymphocytic Leukemia Stem Cell Transplant in Treating Older Patients With Newly Diagnosed Acute Lymphoblastic Leukemia Newly Diagnosed Acute Myeloid Leukemia Treating Older Patients With Acute Myeloid Leukemia Acute Myeloid Leukemia Studying Tissue and Blood Samples From Patients With Acute Myeloid Leukemia Previously Untreated Chronic Lymphocytic Leukemia Limited-Stage Small Cell Lung Cancer Advanced Non-Small Cell Lung Cancer Breast Cancer Stage I or Stage II Hodgkin Lymphoma/Chemotherapy Lymphedema/Breast Cancer Metastatic Breast Cancer, Metastatic Prostate Cancer, or Multiple Myeloma With Bone Involvement Vitamin D and Breast Cancer Biomarkers in Female Patients Metastatic Esophageal Cancer or Gastroesophageal Cancer Stage III Colon Cancer Previously Treated With Surgery Locally Advanced or Metastatic Liver Cancer Genetic Study of Patients With Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndromes, or Multiple Myeloma High-Risk Localized Prostate Cancer Advanced Urinary Tract Cancer Advanced Kidney Cancer Acute Leukemia, Chronic Leukemia, or Myelodysplastic Syndromes Diagnostic Study of Patients With Acute Lymphoblastic Leukemia or Acute Promyelocytic Leukemia Multiple Myeloma Multiple Myeloma Head and Neck Cancer Lymphoblastic Leukemia/Chemotherapy Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia / T-cell Lymphoblastic Lymphoma / Chemotherapy Relapsed Acute Lymphoblastic Leukemia / Lymphoblastic Lymphoma / Bortezomib Newly Diagnosed Acute Lymphoblastic Leukemia Newly Diagnosed Standard-Risk Acute Lymphoblastic Leukemia Combination Chemotherapy/Young Patients/ High-Risk Acute Lymphoblastic Leukemia Acute Myeloid Leukemia / Myelodysplastic Syndromes / Down Syndrome / Chemotherapy Newly Diagnosed Acute Promyelocytic Leukemia / Chemotherapy Study of Blood Samples From Newborns With Down Syndrome Acute Myeloid Leukemia Young Patients With Cancer Acute Myeloid Leukemia Who Are Undergoing Chemotherapy Children With Brain Tumors / Collecting and Storing Samples High-Risk Medulloblastoma / Supratentorial Primitive Neuroectodermal Tumor / Chemotherapy / Radiation Therapy Supratentorial Primitive Neuroectodermal Tumors/High Risk Medulloblastoma Newly Diagnosed Liver Cancer / Young Patients / Chemotherapy Young Patients With Hodgkin’s Lymphoma Late-Occurring Complications in Childhood Cancer Survivors Neuroblastoma / Stem Cell Transplantation Newly Diagnosed Neuroblastoma or Ganglioneuroblastoma Rare or Cutaneous Non-Hodgkin Lymphoma / Collecting and Storing Samples Osteosarcoma / Blood and Tumor Samples High-Risk Kidney Tumors / Chemotherapy / Radiation Therapy Kidney Tumors / Young Patients Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor / Surgery / Vincristine Newly Diagnosed Stage III or Stage IV Wilms' Tumor / Young Patients / Chemotherapy Combination Chemotherapy and Surgery in Treating Young Patients With Wilms Tumor Newly Diagnosed Rhabdomyosarcoma Recurrent or Refractory Rhabdomyosarcoma Rhabdomyosarcoma / Other Soft Tissue Sarcoma Advanced Prostate Cancer HER2/Neu Positive Women With Locally Advanced or Metastatic Breast Cancer Recurrent or Metastatic Head and Neck Cancer Stage IB, Stage II, or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery / Chemotherapy Melanoma That Has Been Removed by Surgery Leukemia / Other Blood Disorders / Collecting Tissue Samples Plasma Cell Disorders Advanced Non-Squamous Non-Small Cell Lung Cancer Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer Newly Diagnosed Glioblastoma Multiforme (GBM)Previously Untreated Stage IV Squamous Non-Small-Cell Lung Cancer (NSCLC ALTTO (Adjuvant Lapatinib And/Or Trastuzumab Treatment Optimisation) Study; BIG 2-06/N063D Gynecological Tumors / Tumor Samples Bevacizumab With or Without Fosbretabulin Tromethamine in Patients With Recurrent or Persistent Ovarian Epithelial, Fallopian Tube, or Peritoneal Cavity Cancer Endometrial Cancer / Surgery / Tissue Samples Persistent Endometrial Cancer Endometrial Cancer Newly Diagnosed Stage III / Stage IV Ovarian Epithelial Cancer / Primary Peritoneal Cavity / Fallopian Tube / Chemotherapy Cervical Lesions/Abnormal Cervical Cells High-Risk Stage I or Stage II Endometrial Cancer Ovarian, Primary Peritoneal, or Fallopian Tube Stage I, Stage II, Stage III, or Stage IVA Endometrial Cancer Incidence of Cancer in Women at Increased Genetic Risk of Ovarian Cancer Chemotherapy With Low-Dose Radiation for Pediatric Hodgkin Lymphoma Therapy for Pediatric Hodgkin Lymphoma Early Stage Breast Cancer Lung Cancer/Avastin (Bevacizumab)Colon Cancer or Rectal Cancer Treating Older Patients With Metastatic Colorectal Cancer Node-Positive or High-Risk Node-Negative, HER2-Negative Breast Cancer Ductal Carcinoma In Situ or Stage I or Stage II Breast Cancer Ductal Carcinoma In Situ Who Have Undergone Lumpectomy Invasive Breast Cancer/Chemotherapy Early-Stage Breast Cancer Stage I or Stage II Colon Cancer Newly Diagnosed Ovarian Epithelial Cancer Grade I, Grade II, or Grade III Meningioma Stereotactic Body Radiation Therapy in Treating Patients With Stage I Non-Small Cell Lung Cancer Prostate Cancer Newly Diagnosed Glioblastoma Locally Advanced Head and Neck Cancer Esophageal Cancer Oropharyngeal Cancer/Radiation Therapy HER2-Negative Metastatic Breast Cancer HER2-Negative Metastatic Breast Cancer HER2-Positive Breast Cancer Receiving Trastuzumab Stage IV or Recurrent Non-Small Cell Lung Cancer / Carboplatin / Paclitaxel Kidney Cancer Patients Who Have Undergone Surgery Treating Patients With Invasive RxPONDER Breast Cancer HER2-Positive Locally Advanced or Metastatic Breast Cancer Hematologic Malignancy

For National Clinical trials, visit these locations:

ClinicalTrials.gov »
National Cancer Institute »

Our Stories

May is Skin Cancer Awareness Month

Skin cancer is the most common form of cancer in the United States.
More than 3.5 million skin cancers are diagnosed each year.
Talk to your doctor about screening for skin cancer.

Learn More Here